Hepatitis C Antibodies

"Hepatitis C Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.

Descriptor ID	D018937
MeSH Number(s)	D12.776.124.486.485.114.254.450.510 D12.776.124.790.651.114.254.450.510 D12.776.377.715.548.114.254.450.510
Concept/Terms	Hepatitis C Antibodies Hepatitis C Antibodies Hepatitis C Virus Antibodies HCV Antibodies Anti-HCV Antibodies Anti HCV Antibodies Anti-Hepatitis C Virus Antibodies Anti Hepatitis C Virus Antibodies

Below are MeSH descriptors whose meaning is more general than "Hepatitis C Antibodies".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Antibodies, Viral [D12.776.124.486.485.114.254]
Hepatitis Antibodies [D12.776.124.486.485.114.254.450]
Hepatitis C Antibodies [D12.776.124.486.485.114.254.450.510]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Antibodies, Viral [D12.776.124.790.651.114.254]
Hepatitis Antibodies [D12.776.124.790.651.114.254.450]
Hepatitis C Antibodies [D12.776.124.790.651.114.254.450.510]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Antibodies, Viral [D12.776.377.715.548.114.254]
Hepatitis Antibodies [D12.776.377.715.548.114.254.450]
Hepatitis C Antibodies [D12.776.377.715.548.114.254.450.510]

Below are MeSH descriptors whose meaning is related to "Hepatitis C Antibodies".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C Antibodies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C Antibodies" by people in this website by year, and whether "Hepatitis C Antibodies" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2009	1	0	1
2012	2	0	2
2016	1	0	1
2020	0	1	1
2024	0	1	1

Below are the most recent publications written about "Hepatitis C Antibodies" by people in Profiles.

Tully DC, Power KA, Sarette J, Stopka TJ, Friedmann PD, Korthuis PT, Cooper H, Young AM, Seal DW, Westergaard RP, Allen TM. Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance. J Viral Hepat. 2024 05; 31(5):266-270.

View in: PubMed
Irvin R, Gamble T, Malone J, Wang Z, Wilson E, Hughes JP, Farley J, Mayer KH, Del Rio C, Batey DS, Cummings V, Remien RH, Beyrer C, Thio CL. HIV Prevention Trials Network 078: High Prevalence of Hepatitis C Virus Antibodies Among Urban US Men Who Have Sex With Men, Independent of Human Immunodeficiency Virus Status. Clin Infect Dis. 2021 10 05; 73(7):e2205-e2210.

View in: PubMed
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 03 10; 323(10):970-975.

View in: PubMed
Smith HL, Chung RT, Mantry P, Chapman W, Curry MP, Schiano TD, Boucher E, Cheslock P, Wang Y, Molrine DC. Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study. J Viral Hepat. 2017 03; 24(3):197-206.

View in: PubMed
Zhang S, Kodys K, Li K, Szabo G. Human type 2 myeloid dendritic cells produce interferon-? and amplify interferon-a in response to hepatitis C virus infection. Gastroenterology. 2013 Feb; 144(2):414-425.e7.

View in: PubMed
Morin TJ, Broering TJ, Leav BA, Blair BM, Rowley KJ, Boucher EN, Wang Y, Cheslock PS, Knauber M, Olsen DB, Ludmerer SW, Szabo G, Finberg RW, Purcell RH, Lanford RE, Ambrosino DM, Molrine DC, Babcock GJ. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog. 2012; 8(8):e1002895.

View in: PubMed
Broering TJ, Garrity KA, Boatright NK, Sloan SE, Sandor F, Thomas WD, Szabo G, Finberg RW, Ambrosino DM, Babcock GJ. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J Virol. 2009 Dec; 83(23):12473-82.

View in: PubMed
Jain A, Menegus M, Mohanka R, Orloff M, Abt P, Mantry P, Bozorgzadeh A. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice? Exp Clin Transplant. 2006 Jun; 4(1):475-80.

View in: PubMed
Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine. Transplant Proc. 2005 Sep; 37(7):3187-9.

View in: PubMed
Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol. 2004 Nov; 78(22):12252-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals